Eppen_TracePCR_Dec24
  Editorial
 A SCHEME TO UNLEASH INNOVATION POTENTIAL   
 Wednesday, November 19, 2025 
 The Department of Pharmaceuticals (DoP) has recently notified the amendments to the Rs. 5,000 crore Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme which will build an advanced 
  Past Editorial...  
TODAY'S NEWS
12:00  [IST]Pfizer & Astellas announce US FDA approves Padcev plus Keytruda for certain patients with bladder cancer
11:45  [IST]TNCDA's Villupuram meeting of November 23 ratified expulsion of K K Selvan from secretary’s post
11:00  [IST]AGC Biologics to produce AAVantgarde Bio’s dual-vector gene therapies for inherited retinal disorders
10:00  [IST]Shimadzu Medical Systems releases MobileDaRt Evolution MX9 Version
09:00  [IST]AstraZeneca plans to invest $2 billion to expand manufacturing footprint in Maryland
more news >>
TOP NEWS
08:00  [IST]CDSCO asks procurement agencies to mandate Indian license as technical requirement
08:00  [IST]Raids expose sale of fake & poor-quality drugs in discount pharmacies across Kerala
08:00  [IST]Karnataka calls on its pharma players to scale operations in its five designated pharma park regions
08:00  [IST]CDSCO reports highest number of NSQs in 2025 in October
08:00  [IST]Indian pharma ramps up quality & compliance efforts to meet evolving oral dosage form BA/BE requirements
08:00  [IST]DCGI directs state regulators to mandate display of PvPI's QR code in pharmacy premises
more news >>
YESTERDAY'S NEWS
18:00  [IST]Contineum Therapeutics phase 2 PIPE-307 VISTA trial to treat RRMS fails to meet its prespecified primary or secondary efficacy endpoints
17:00  [IST]BioNxt Solutions receives Eurasian Patent for sublingual cladribine platform
16:00  [IST]iZafe Group inks distribution agreement with Skand to launch of Dosell on the Icelandic market
15:00  [IST]Call for expressions of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee
14:00  [IST]Alvotech & Advanz Pharma receive marketing approval across the EEA for Gobivaz, a first-in-market biosimilar to Simponi
13:00  [IST]Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil as part of first-line regimen in adults with severe acute GvHD refractory to steroids
more news >>
INTERVIEW  
Future of pharmacy trade lies in blending tradition with innovation
B Thirunavukkarasu, President, The Bangalore District Chemists and Druggists Association
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram